相关实验视频
Updated: Sep 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
在冠状动脉囊患者的阿洛普林醇治疗后,心肌输血和心痛改善
Sara D V Ziotti1, Renato P Azevedo2, Thiago L V Pereira3
1Centro de Pesquisa Clinica Prof. Fulvio Pileggi, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil; Unidade de Prevencao, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.
冠状动脉囊 (CAF) 可以引起心痛. 一种高剂量阿洛普林醇治疗方案改善了弱小的CAF患者的症状和心肌输液,不适合干预.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉抽 (CAF) 可以导致心肌缺血和心痛,即使没有阻塞性冠状动脉疾病.
- 目前,没有任何非干预策略被证明可以改善CAF引起的耐火性心痛患者的症状或缺血.
相关概念视频
Angina IV: Management
Coronary Artery Disease V: Interprofessional Care
Angina V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

